Back to Journals » Vascular Health and Risk Management » Volume 14

Clinical accuracy of the Omron M3 Comfort® and the Omron Evolv® for self-blood pressure measurements in pregnancy and pre-eclampsia – validation according to the Universal Standard Protocol

Authors Topouchian J, Hakobyan Z, Asmar J, Gurgenian S, Zelveian P, Asmar R

Received 14 February 2018

Accepted for publication 12 June 2018

Published 31 August 2018 Volume 2018:14 Pages 189—197


Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 3

Editor who approved publication: Dr Daniel Duprez

Jirar Topouchian,1 Zoya Hakobyan,2 Jennifer Asmar,3 Svetlana Gurgenian,4 Parounak Zelveian,2 Roland Asmar5

1Diagnosis and Therapeutic Center, Hôtel Dieu Hospital, Paris, France; 2Department of Preventive Cardiology, Institute of Cardiology, Yerevan, Armenia; 3Department of Gynecology-Obstetric, Foch Hospital, Suresnes, France; 4Department of Arterial Hypertension, Institute of Cardiology, Yerevan, Armenia; 5Foundation-Medical Research Institutes (F-MRI)®, Geneva, Switzerland

Background: Electronic devices for blood pressure (BP) measurements need to go through independent clinical validation as recommended by different authorities, both in general and in special populations such as pregnancy.
Objective: To evaluate the accuracy of the Omron Evolv® (HEM-7600T-E) and the Omron M3 Comfort® (HEM-7134-E) devices in pregnancy and pre-eclampsia according to the Universal Standard Validation Protocol.
Methods: Both devices, the Evolv and the M3 Comfort, measure BP at the brachial level using the oscillometric method. The study was performed according to the recently published protocol, the so-called “modified Advancement of Medical Instrumentation (AAMI)/British Hypertension Society (BHS)/European Society of Hypertension (ESH) protocol” or the “Universal Standard Protocol.” Validation of each device included 45 pregnant women in the second and third gestational trimester of whom 15 had pre-eclampsia, 15 had gestational hypertension and 15 were normotensives. BP differences between the observer and the device BP values were classified into three categories (≤5, ≤10, and ≤15 mmHg) and the mean BP differences (test vs reference) and its SD were calculated.
Results: Both devices, the Evolv and the M3 Comfort, achieved a grade A/A in both pregnancy and pre-eclampsia. The mean difference (SD) between the mercury standard and the device BP values in pregnancy were: 1) for the Evolv of –0.7±2.3 mmHg for systolic blood pressure (SBP) and –0.1±1.8 mmHg for diastolic blood pressure (DBP); 2) for the M3 Comfort of –1.6±2.8 mmHg for SBP and –0.1±2.3 mmHg for DBP.
Conclusion: Both devices, the Evolv and the M3 Comfort, achieved a grade A/A for both SBP and DBP and fulfill the validation protocol criteria in pregnancy and pre-eclampsia. Consequently, these two devices can be recommended for home BP measurements in this specific population.

Keywords: blood pressure, blood pressure measurements, validation, pregnancy, pre-eclampsia, home blood pressure, self-BP measurement

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]